Assistant Health Scientist to lead a research line in Molecular Imaging and Nanomedicine applied to the cardiovascular system
* TEMPORARY CONTRACT (“Contrato de investigador/a distinguido/a” - ART. 23 Ley 14/2011 de la Ciencia, la Tecnología y la Innovación)
REF: ASSIST HEALTH SCIENTIST-02.24
IMPORTANT: The interested person must send the Curriculum Vitae, the degree and the work life report MANDATORY through the CNIC application web, which can be found at the following link:
https://www.cnic.es/es/convocatoria/assistant-health-scientist-lead-research-line-molecular-imaging-and-nanomedicine
Requests that are not sent through the CNIC website cannot be accepted
The Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) (CNIC) has been conceived to develop research of excellence, competitive and of international relevance in relation to cardiovascular diseases. The CNIC has a research center of 24,000 m2, located in Madrid, with more than 6,000 m2 for laboratories equipped with a state-of-the-art infrastructure and equipment.
Functions:
The selected candidate will be responsible for the development of the research lines of a laboratory, which is expected to focus on the development of molecular imaging technologies and nanomedicine to improve diagnosis and treatment of cardiovascular disease. Moreover, she/he will be expected to obtain extramural funding from the most competitive national and international sources to finance such projects, and to publish scientific results in international journals of the highest impact factor in the cardiovascular field, and/or general medicine field, and/or multidisciplinary sciences field. The selected candidate will supervise the work of all members of the group, including research and technical staff. Other tasks include the coordination and management work requested by CNIC leadership including participation in committees and helping in other needs that may arise.
Mandatory Requirements:
1. PhD in the field of Life Sciences (Biology, Chemistry, Medicine, etc.)
2. A minimum of 5 years and no more than 10 years of experience leading a research group in the field of molecular imaging or nanomedicine in an internationally recognized research center.
3. A minimum of 2 articles as main author (first, last or corresponding author) in journals in the field of molecular imaging and/or cardiovascular disease in the last 5 years (i.e., since 2019).
4. Experience as Principal Investigator/Coordinator in research grants obtained from national and/or international competitive funding sources in the last 5 years (i.e. year of publication of the call: 2019 onwards).
5. Main topic of research in the field of nanomedicine and molecular imaging applied to the cardiovascular system.
Valuable Requirements:
• C1. Scientific production: publications as main author (first, last or corresponding author) in journals in the field of nanomedicine and molecular imaging applied to cardiovascular disease in the previous 5 years (i.e. date of publication since 2019). Only published papers (or available online ahead of print in the journal) will be evaluated. The CV must include the complete list of authors, the journal´s IF and ranking in the year of publication for each publication published since 2019. This criterion will be valued according to the number of papers.
• C2. Fundraising (international): Projects obtained from international funding sources as Principal Investigator/Coordinator in the previous 5 years (i.e. active projects in 2019 onwards). The CV must include each project, indicating the role of the candidate in the grant, amount granted, period of funding, and funding agency. This criterion will be valued according to the relevance of the funding source (being European Commission-funded projects considered the highest), the amount granted, and the number of projects. This criterion will be valued according to the relevance of the funding source (being European Commission-funded projects considered the highest), the amount granted, and the number of projects.
• C3. International recognition: Participation in international committees/boards, grant evaluation panels, editorial boards, and invited seminars/conferences in international centers/meetings in the previous 5 years (i.e. since 2019). This criterion will be valued according to the relevance of the boards, role played in these, and number of activities.
• C4. Cardiovascular focus: Nature of the papers published as main author (first, last or corresponding author) and of the projects as principal investigator in the previous 5 years (i.e. since 2019) in the field of nanomedicine and molecular imaging applied to the cardiovascular system. This criterion will be evaluated as the weight of nanomedicine and molecular imaging research in the overall scientific production and fundraising of the candidate.
• C5. Interview
We offer:
• A research position in a consolidated Research Center of international scientific relevance.
• Access to state-of-the art infrastructures and advanced technologies.
• Integration into an excellent scientific environment.
• Immediate incorporation adaptable to the candidate circumstances
• 5-years temporary position as “Contrato de investigador/a distinguido/a”. Distinguished investigator contract regulated by the article 23 of the Spanish Law, on Science, Technology and Innovation (texto refundido Ley 14/2011, de 1 de junio, de la Ciencia, la Tecnología y la Innovación.
Recruitment Plan:
La RESOLUCIÓN DE LA SECRETARÍA DE ESTADO DE FUNCIÓN PÚBLICA POR LA QUE SE APRUEBAN LOS CRITERIOS DE ACTUACION COMUNES EN LOS PROCESOS SELECTIVOS DE LAS ENTIDADES DEL SECTOR PÚBLICO ESTATAL de 11 de abril de 2022, establece en el punto 6.1 que “Salvo que una normativa específica prevea el sistema selectivo de concurso, el sistema selectivo será el de concurso-oposición”
In CNIC, the specific regulations approved by the Foundation's board of trustees establish a merit-base recruitment system (concurso) including a personal interview.
At least 3 candidates with the highest score will be interviewed (as long as they reach the minimum of 70 points in the total of the evaluation criteria, C1-C4, see below). The candidate with the highest score will be hired given the total score is higher than 85 points (C1-C5).
Recruitment Commission:
• Scientific Director
• Basic Research Director
• Coordinator of the Novel mechanisms of atherosclerosis programme
• Scientific Management and Head of training department
• Research Office Coordinator
• HHRR
"In the event of absence of any of the evaluators an alternate evaluator will be appointed"
The CNIC guarantees, within its field of action, the principle of equal access to employment, and may not establish any direct or indirect discrimination, based on grounds of origin, including racial or ethnic origin, sex, age, marital status, religion or beliefs, political opinion, sexual orientation and identity, gender expression, sexual characteristics, trade union membership, social status, language within the State and disability, provided that workers are fit to perform the work or job in question.
By participating in the selection process, the participant agrees that their data appear in the public resolutions of the selection process. Such resolutions (provisional list of admitted and excluded, definitive list of admitted and excluded and resolution of the process) are published on the CNIC website.
Evaluation Criteria:
C1 - Scientific production: publications as main author (first, last or corresponding author) in journals in the field of nanomedicine and molecular imaging applied to cardiovascular disease in the previous 5 years (i.e. date of publication since 2019). Only published papers (or available online ahead of print in the journal) will be evaluated. The CV must include the complete list of authors, the journal´s IF and ranking in the year of publication for each publication published since 2019. This criterion will be valued according to the number of papers
This criterion will be valued according to the number of papers. 15%
C2 - Fundraising (international): Projects obtained from international funding sources as Principal Investigator/Coordinator in the previous 5 years (i.e. active projects in 2019 onwards). The CV must include each project, indicating the role of the candidate in the grant, amount granted, period of funding, and funding agency. This criterion will be valued according to the relevance of the funding source (being European Commission-funded projects considered the highest), the amount granted, and the number of projects.
This criterion will be valued according to the relevance of the funding source (being European Commission-funded projects considered the highest), the amount granted, and the number of projects. 30%
C3 - International recognition: Participation in international committees/boards, grant evaluation panels, editorial boards, and invited seminars/conferences in international centers/meetings in the previous 5 years (i.e. since 2019). This criterion will be valued according to the relevance of the boards, role played in these, and number of activities. 10%
C4 - Cardiovascular focus: Nature of the papers published as main author (first, last or corresponding author) and of the projects as principal investigator in the previous 5 years (i.e. since 2019) in the field of nanomedicine and molecular imaging applied to the cardiovascular system.
This criterion will be evaluated as the weight of nanomedicine and molecular imaging research in the overall scientific production and fundraising of the candidate. 25%.
C6 - Interview 20%
"En caso de ausencia de alguno de los evaluadores se nombrará un evaluador alternativo de la misma área"